Appeals court rules for FTC on HSR rulemaking on pharmaceuticals

(June 12, 2015) -- A three-judge panel of the U.S. Court of Appeals for the District of Columbia Circuit ruled that the Federal Trade Commission was within its rights to write rules targeting a specific industry with certain pre-merger notification requirements....

Related Sections